Loading [MathJax]/jax/output/SVG/jax.js
Review Topical Sections

Urinary VPAC1: A potential biomarker in prostate cancer

  • Received: 18 January 2022 Revised: 25 April 2022 Accepted: 10 May 2022 Published: 31 May 2022
  • Prostate cancer is ranked as the fourth most prevalent cancer commonly diagnosed among males over 40 years of age, according to the WHO Cancer Fact Sheet 2020, and it is additionally a leading cause of cancer mortality among males. The incidence of prostate cancer and mortality varied significantly across the globe. Diagnosis of prostate cancer hinders easier management of cases, and prostate-specific antigen (PSA) use for screening of prostate cancer has poor specificity and sensitivity, thereby yielding overdiagnosis and unnecessary biopsies. Radiologically guided (ultrasound/MRI) prostate biopsy, considered the gold standard, is invasive and can miss a significant number of metastatic cancers. Even though mild, other prostate biopsy complications occur on a large scale, and few severe ones are often recorded. Scientists intensify their search for biomarker(s) for non-invasive diagnosis of prostate cancer using proteomics, metabolomics, genomics, and bioinformatics—urinary biomarkers were uniquely on the lookout. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP) receptor 1 (VPAC1), which is overexpressed (a thousandfold) in prostate cancer at the onset of oncogenesis and is excreted in the urine on tumor cells, is a contender in the prostate cancer biomarker quest. VPAC1 is ubiquitous, expressed by normal and malignant cells, and interwoven in their cell membranes. Therefore, using urine samples limits the possibility of making the wrong diagnosis, since VPAC1 is not normally excreted in the urine. Nevertheless, studying transmembrane receptors is intricate. However, producing monoclonal antibodies against the N-terminal end of VPAC1 can provide a promising target for designing a non-invasive diagnostic assay for early detection of prostate cancer using a urine sample.

    Citation: Mansur Aliyu, Ali Akbar Saboor-Yaraghi, Shima Nejati, Behrouz Robat-Jazi. Urinary VPAC1: A potential biomarker in prostate cancer[J]. AIMS Allergy and Immunology, 2022, 6(2): 42-63. doi: 10.3934/Allergy.2022006

    Related Papers:

    [1] Jose Manuel Torres Espino, Emilio Barchiesi . Computational study of a homogenized nonlinear generalization of Timoshenko beam proposed by Turco et al.. Networks and Heterogeneous Media, 2024, 19(3): 1133-1155. doi: 10.3934/nhm.2024050
    [2] Zhong-Jie Han, Gen-Qi Xu . Dynamical behavior of networks of non-uniform Timoshenko beams system with boundary time-delay inputs. Networks and Heterogeneous Media, 2011, 6(2): 297-327. doi: 10.3934/nhm.2011.6.297
    [3] Kaïs Ammari, Mohamed Jellouli, Michel Mehrenberger . Feedback stabilization of a coupled string-beam system. Networks and Heterogeneous Media, 2009, 4(1): 19-34. doi: 10.3934/nhm.2009.4.19
    [4] Gilles Pijaudier-Cabot, David Grégoire . A review of non local continuum damage: Modelling of failure?. Networks and Heterogeneous Media, 2014, 9(4): 575-597. doi: 10.3934/nhm.2014.9.575
    [5] Yannick Holle, Michael Herty, Michael Westdickenberg . New coupling conditions for isentropic flow on networks. Networks and Heterogeneous Media, 2020, 15(4): 605-631. doi: 10.3934/nhm.2020016
    [6] Antonio DeSimone, Martin Kružík . Domain patterns and hysteresis in phase-transforming solids: Analysis and numerical simulations of a sharp interface dissipative model via phase-field approximation. Networks and Heterogeneous Media, 2013, 8(2): 481-499. doi: 10.3934/nhm.2013.8.481
    [7] Serge Nicaise, Cristina Pignotti . Asymptotic analysis of a simple model of fluid-structure interaction. Networks and Heterogeneous Media, 2008, 3(4): 787-813. doi: 10.3934/nhm.2008.3.787
    [8] Hyunjin Ahn . Asymptotic flocking of the relativistic Cucker–Smale model with time delay. Networks and Heterogeneous Media, 2023, 18(1): 29-47. doi: 10.3934/nhm.2023002
    [9] Adrian Muntean, Toyohiko Aiki . Preface to ``The Mathematics of Concrete". Networks and Heterogeneous Media, 2014, 9(4): i-ii. doi: 10.3934/nhm.2014.9.4i
    [10] Yin Yang, Aiguo Xiao . Dissipativity and contractivity of the second-order averaged L1 method for fractional Volterra functional differential equations. Networks and Heterogeneous Media, 2023, 18(2): 753-774. doi: 10.3934/nhm.2023032
  • Prostate cancer is ranked as the fourth most prevalent cancer commonly diagnosed among males over 40 years of age, according to the WHO Cancer Fact Sheet 2020, and it is additionally a leading cause of cancer mortality among males. The incidence of prostate cancer and mortality varied significantly across the globe. Diagnosis of prostate cancer hinders easier management of cases, and prostate-specific antigen (PSA) use for screening of prostate cancer has poor specificity and sensitivity, thereby yielding overdiagnosis and unnecessary biopsies. Radiologically guided (ultrasound/MRI) prostate biopsy, considered the gold standard, is invasive and can miss a significant number of metastatic cancers. Even though mild, other prostate biopsy complications occur on a large scale, and few severe ones are often recorded. Scientists intensify their search for biomarker(s) for non-invasive diagnosis of prostate cancer using proteomics, metabolomics, genomics, and bioinformatics—urinary biomarkers were uniquely on the lookout. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP) receptor 1 (VPAC1), which is overexpressed (a thousandfold) in prostate cancer at the onset of oncogenesis and is excreted in the urine on tumor cells, is a contender in the prostate cancer biomarker quest. VPAC1 is ubiquitous, expressed by normal and malignant cells, and interwoven in their cell membranes. Therefore, using urine samples limits the possibility of making the wrong diagnosis, since VPAC1 is not normally excreted in the urine. Nevertheless, studying transmembrane receptors is intricate. However, producing monoclonal antibodies against the N-terminal end of VPAC1 can provide a promising target for designing a non-invasive diagnostic assay for early detection of prostate cancer using a urine sample.


    Abbreviations

    PSA:

    prostate-specific antigen; 

    VIP:

    vasoactive intestinal peptide; 

    PACAP:

    pituitary adenylate cyclase-activating peptide; 

    VPAC1:

    VIP/PACAP receptor 1; 

    ASR:

    age-standardized rate; 

    BPH:

    benign prostatic hypertrophy; 

    DHT:

    5α-dihydrotestosterone; 

    RTqPCR:

    quantitative reverse transcription polymerase chain reaction; 

    MRI:

    magnetic resonance imaging; 

    mp-MRI:

    multiparametric MRI; 

    DCE-MRI:

    dynamic contrast-enhanced MRI; 

    DWI-MRI:

    diffusion-weighted imaging MRI; 

    TRUS:

    trans-rectal ultrasound scan; 

    ELISA:

    enzyme-linked immunosorbent assay; 

    PCA3:

    prostate cancer antigen 3; 

    TMPRSS2:

    transmembrane protease serine 2; 

    GSTP1:

    glutathione S-transferase P1; 

    DRE:

    digital rectal examination; 

    AUC:

    area under the curve; 

    aHGF:

    hepatocyte growth factor; 

    IGFBP3:

    insulin-like growth factor binding protein 3; 

    OPN:

    Plasma osteopontin; 

    LNCaP:

    lymph node carcinoma of the prostate; 

    GPCRs:

    G protein-coupled receptors; 

    RAMPS:

    receptor activity modifying proteins; 

    7-TMD:

    seven-transmembrane domain; 

    ECD:

    extracellular domain; 

    CHO:

    Chinese hamster ovary; 

    TBP:

    TATA-box binding protein; 

    COX-2:

    cyclooxygenase-2; 

    MMP9:

    metalloproteinase 9; 

    uPA:

    urokinase plasminogen activator; 

    uPAR:

    uPA receptor; 

    DAPI:

    4,6-diamidino-2-phenylindole; 

    AC:

    adenylyl cyclase; 

    CREB:

    cAMP response element-binding protein; 

    PKA:

    phosphokinase A; 

    iNOS:

    inducible nitric oxide synthase; 

    CBP:

    CREB binding protein; 

    NF-κβ:

    nuclear factor-κβ; 

    ERK:

    extracellular signal-regulated kinase; 

    MEKK1:

    MAP/ERK kinase (MEK) kinase 1; 

    IRF-1:

    IFN regulatory factor-1; 

    IKK:

    inhibitory κβ kinase; 

    BB-LP:

    bombesin-like peptides; 

    GRPR:

    gastrin-releasing peptide receptor; 

    PLC:

    phospholipase C; 

    DAG:

    diacylglycerol; 

    IP3:

    1,4,5-triphosphate; 

    PKC:

    protein kinase C; 

    MAPK:

    mitogen-activated protein kinase; 

    MAPKK:

    mitogen-activated protein kinase kinase; 

    ELK:

    ETS like-1 protein; 

    SRE:

    serum response element

    It is remarkable that despite its widespread use in civil engineering, concrete remains relatively unknown. Indeed, in technical practice, oversimplified models that ignore some essential aspects are used. From ancient times to the present day, human structures have been crafted from concrete, initially comprising rudimentary cement made by crushing and burning gypsum or limestone. Over the course of civil engineering history, concrete has evolved into a sophisticated composite material. Nowadays, concrete is a fundamental construction material that plays a pivotal role in shaping our built environment, providing stability, durability, and versatility in a wide range of construction projects. Ongoing research in concrete technology is crucial for advancing the construction industry, promoting sustainability, enhancing safety, and meeting the evolving demands of our built environment.

    Among some of the most significant current research areas concerning concrete, we can summarize the following categories: ⅰ) supplementary cementitious materials (SCMs); ⅱ) nanotechnology; ⅲ) self-healing concrete; ⅳ) ultra-high-performance concrete (UHPC); ⅴ) digital tools in concrete design.

    SCMs are materials like fly ash, slag, and silica fume that can be added to concrete in addition to Portland cement to improve its properties and reduce its carbon footprint [1,2,3]. By incorporating these SCMs into concrete mixtures, construction professionals can decrease the amount of Portland cement needed, a significant source of carbon emissions in concrete production. This substitution not only improves the technical properties of concrete but also contributes to more sustainable and environmentally friendly construction practices, making it an essential aspect of modern concrete research and construction [4].

    Incorporating nanomaterials into concrete formulations represents a promising possibility for enhancing the mechanical properties and longevity of the material. This research area is continually evolving and has the potential to revolutionize the construction industry by producing stronger, more durable, and sustainable concrete structures. Potentially, the inclusions could be nanoparticles [5], fibers [6,7,8], and suitable complex microstructures enancing the performaces [9,10,11]. Nanotechnology applied to concrete can improve particle packing and reduce permeability. Nanoparticles are much smaller in size than traditional concrete materials. When incorporated into the concrete mix, they fill in the gaps between larger particles, improving particle packing. This denser packing enhances the concrete's overall strength and reduces porosity, increasing surface area. Nanomaterials, such as nano-silica or nanotubes, have a high surface area-to-volume ratio [12]. This increased surface area allows for better bonding with cement particles and enhances chemical reactions. Moreover, they can be employed to form additional cementitious compounds that contribute to increased strength and durability, increased flexural and compressive strength, and shifting of the mitigation of early-age cracking. Nanomaterials can help mitigate early-age cracking by reducing the heat of hydration, controlling the formation of microcracks, and improving the overall curing process.

    Research on self-healing concrete focuses on developing innovative materials and techniques that allow it to repair its cracks autonomously [13]. This area of study is essential for improving the durability and longevity of concrete structures. The idea of self-healing originates from the aim to enhance the performance of building materials like concrete with extra features mimicking the behavior of biological tissues, such as bone (see, e.g., [14,15] to exploite mechanical properties, and [16,17,18,19] for biologocal processes that allow the healing of the tissue). Key aspects of research on self-healing concrete are self-healing mechanisms, healing agents, and microstructural changes. Self-healing concrete typically relies on several mechanisms, including autogenous and encapsulated healing. Autogenous healing occurs when unhydrated cement particles in the presence of water fill small cracks through continued hydration, sealing the crack [20]. Encapsulated healing involves the use of microcapsules containing healing agents embedded in the concrete. When a crack forms, these capsules rupture, releasing healing agents that react and seal the crack [21]. Various healing agents can be embedded in self-healing concrete, such as bacteria, polymers, or organic and inorganic materials. Bacteria-based systems use specially designed bacteria that produce calcium carbonate (CaCO3) when exposed to moisture and oxygen. This CaCO3 seals cracks by precipitating in them. Polymer-based systems rely on the expansion of polymers to seal cracks. These polymers can be embedded within the concrete mix or applied as an external layer. This field of research aims to understand how self-healing affects the microstructure of concrete, ensuring that the healing process does not compromise the overall strength and durability of the material. Techniques like scanning electron microscopy (SEM) and X-ray micro-computed tomography (μ-CT) are used to analyze the effectiveness of self-healing mechanisms.

    UHPC is a relatively recent development in the field of concrete technology [22]. It is characterized by its exceptional strength, durability, and unique properties that distinguish it from traditional concrete. UHPC typically comprises a precise blend of materials, including Portland cement, fine quartz or silica fume, very fine sand, high-range water-reducing admixtures, and sometimes steel fibers. The exact mix design can vary but is characterized by the use of outstanding materials and minimal water content.

    Moreover, ultra high performance fiber-teinforced concrete (UHP FRC) is an advanced concrete variant that incorporates high-strength fibers to significantly enhance its mechanical and durability properties [23]. Characterized by a compressive strength greater than 150 MPa, UHP FRC surpasses conventional concrete, which typically ranges from 20 to 50 MPa. The inclusion of fibers like steel, glass, or synthetic materials boosts its tensile strength and ductility, enabling it to withstand greater tensile forces and deform more without cracking. UHP FRC features a dense matrix with very low porosity, making it highly resistant to water penetration and chemical attacks. This density is achieved through optimized particle packing and the use of fine powders such as silica fume, fly ash, and superplasticizers. The combination of a dense matrix and high fiber content results in exceptional durability, providing resistance to freeze-thaw cycles, abrasion, and aggressive environments. Typically self-consolidating, UHP FRC flows and fills complex molds without the need for mechanical vibration, facilitating the creation of intricate architectural elements. The components of UHP FRC include high-quality Portland cement as the primary binder, fine aggregates to ensure dense particle packing, silica fume to fill voids and increase strength, superplasticizers to enhance workability and fluidity without increasing water content, and high-strength fibers like steel, glass, polypropylene, or carbon to improve tensile strength and ductility. UHP FRC finds applications in bridges and infrastructure, architectural elements, repair and rehabilitation, and security and defense structures due to its high strength, durability, and impact resistance. Its advantages lie in its superior mechanical properties, exceptional durability, design flexibility, and potential contributions to sustainable construction through reduced material usage and longer lifespan. However, the production of UHP FRC is more costly than conventional concrete, requiring precise mix design, quality control, and specialized knowledge for design and construction. Despite these challenges, UHP FRC stands out as a cutting-edge material suitable for demanding applications in modern construction.

    Computer simulations and modeling play a crucial role in designing and optimizing concrete structures. These tools provide technicians and engineers with valuable insights, enabling them to make informed decisions, improve designs, and enhance the overall performance of concrete structures. Computer simulations and modeling provide a comprehensive and detailed understanding of how concrete structures perform in real-world conditions. This knowledge allows for more efficient and sustainable designs, reduced construction costs, improved safety, and enhanced durability, ultimately leading to better-engineered concrete structures. For instance, potential applications of this method include 3D modeling of concrete [24,25], research focused on optimizing key aspects of concrete performance or its internal structure [26,27,28], and aided design techniques [29,30,31].

    Fundamentally, it is the internal microstructure of concrete that defines its unique properties. Comprising components like Portland cement, sand, and gravel of various sizes and shapes, concrete is a highly heterogeneous material. Its strength is significantly influenced by factors such as the water-to-cement ratio and the incorporation of additives that chemically or mechanically alter its properties.

    Describing the behavior of concrete poses numerous challenges from a modeling perspective. Among these challenges, the key is its nonlinear behavior both at the macro level of observation, in a standard context [32,33,34], as well as in porous materials [35], and at the microscopic level [36,37], even under small deformations. The dissipative effects stemming from its microstructure in both elastic and plastic regimes[38] and the evolution of cracks within it [39] are also crucial.

    At its core, the microstructure of concrete consists of a matrix formed by the solid phase of the cement paste, interspersed with pieces of inert material of varying sizes. Additionally, the microstructure is further complicated by factors such as chemical species and thermal cycles during curing, which naturally give rise to microcracks within the material. While these microcracks impact the macroscopic behavior of concrete, their effects remain subdued unless subjected to significant external loads [40].

    Various models have been explored in the literature to predict concrete behavior. In addition to traditional models like the Cauchy model, alternative approaches within the framework of generalized continua have been investigated. Among them, we recall the second-gradient continua [41,42,43,44] or even of higher order [45], micromorphic continua [46,47,48], and functionally graded materials [49]. These include also Cosserat-type models to account for the presence of stiff aggregates and higher gradient continua to address the material strong heterogeneity (see, e.g., [50,51,52,53,54]).

    Furthermore, concrete can be treated as a porous material due to voids formed during the curing process and microcracks [55,56]. These microcracks, in particular, affect concrete behavior by introducing asymmetry in its mechanical response due to compressive or tensile loads, and generating internal friction under cyclic compressive loads.

    Modeling the dissipation in concrete presents a significant challenge. While viscous models are commonly used, they often offer a simplistic linearization of dissipative actions. Alternatively, Coulomb-type friction between microcrack surfaces is proposed as a more appropriate mechanism for dissipative behavior, which remains nearly independent of frequency. Rheological models and thermodynamic frameworks with diffusive internal variables are also employed to address dissipation in solid materials [57,58,59].

    Finally, while this paper primarily focuses on dissipative effects in concrete under small deformations, it is important to acknowledge ongoing research efforts related to plasticity and damage evolution (see, e.g., [60,61,62,63]). Variational formulations are favored for their logical consistency and ability to minimize unnecessary assumptions (see, e.g., applications to damage formulation [64,65,66], buckling [67], internal friction in solid materials [68,69], and thermoelastic theory [70]). Recent studies explored the use of material particles akin to swarms of robots, offering promising computational efficiency [71].

    In summary, this work aims to explore the Coulomb nature of dissipative effects in concrete due to the mechanics of microcracks through numerical simulations obtained for a 1D generalized model, which is an enhanced version of the Timoshenko beam, built upon a previously introduced 3D model [72]. The proposed Timoshenko-like beam is a very efficient and powerful tool for quickly assessing material behavior. This novel beam model shows an improved capability to analyze the behavior of materials under certain circumstances, subsequently providing significant advantages over traditional beam models. In comparison with traditional beam models, this Timoshenko-like beam is more effective in predicting the dissipation in materials that are subjected to cyclic loads, and, as in the standard case, it is capable of more accurately predicting the effects of shear deformation. As a result of these improvements, the Timoshenko-like beam model can provide engineers and researchers with greater insight into the behavior of materials and allow them to make more informed decisions when designing structures and mechanical components.

    The present section concerns a planar 1D model of a cement-based beam that can be described primarily by a reference curve C in the plane xy, which lies on the x-axis in its undeformed configuration and whose length is L. The current configuration of the beam, C, is represented by the map χ, which depends on a generic S-abscissa, as illustrated in Figure 1. To this end, we propose to enlarge the standard kinematical description used in the Timoshenko model with a further descriptor that is able to take into account, to some extent, the sliding effect of the opposite faces of microcracks within the cement matrix [38,72,73]. Since we consider the small displacement and small deformation regime, we assume that the density of microcracks remains the same throughout the tests; thus, no damage evolution occurs. The fundamental kinematic assumption in the Timoshenko model is that, although the conservation of plane cross-sections and their rigidity apply, the orthogonality between the axial beam line and the cross-section is not retained. This refers to the hypothesis in which the influence of shear distortion on the beam deformation is not neglected [74]. The complete kinematical description of the system configuration is specified by means of the kinematic variables: u, v, φ, and γ. Expressly, these kinematical descriptors represent the longitudinal and transverse displacement of the beam axis, the cross-section rotation, and an average inner relative sliding between the opposite faces of microcracks, respectively. The first three variables are characteristic of the classical Timoshenko model accounting for extension, while the novel-introduced variable is assumed to be a scalar field since, as a first approximation, we can postulate that no preferential direction characterizes the microcracks and a random distribution of their orientation is in place [72,75]. Thus, we define the map χ as:

    χ:={r={x=S+u(S)y=v(S)ˆφ=φ(S)ˆγ=γ(S), (2.1)

    where the vector r specifies the position of the material particles lying on the axial line of the beam, and ˆφ and ˆγ are the characteristic features that describe the essential properties of the microstructure, i.e., the orientation of the cross-section and the sliding in the microcracks.

    Figure 1.  Kinematic descriptors of the beam (on the left); scheme of the microcrack microstructure of the beam material (on the right). τc and nc are the tangent and normal unit vectors to the axial curve of the beam, while τs and ns are the tangent and normal unit vectors to the beam cross-section. The red lines on the concrete section represent the microcracks; thus, γ can be interpreted as a descriptor of micro-slip accumulation within the material.

    In order to characterize the behavior of the considered system, we employ an expanded version of the principle of virtual work (PVW). This principle states that, at equilibrium, the virtual work exerted by the external forces applied to the system, denoted by δWext, must balance the virtual work performed by the internal contact forces, namely, δWel for the conservative part associated with the elastic deformation, as well as any virtual work dissipated within the system, ˜δD, for the same virtual displacements; therefore, we consider the extended principle of virtual work as follows:

    δWel+˜δD=δWext, (2.2)

    neglecting the inertial effects since we consider low-frequency applications of the materials. In this extended version of the variational principle, it is important to note that the dissipative contribution is not calculated as the first variation of D. As a result, we use a different symbol, ˜δ, to account for the Rayleigh extension of Lagrangian formalism for dissipation.

    The inner virtual work related to the elastic deformation is evaluated starting from a plausible expression of an elastic deformation energy based on the abovementioned kinematic variables:

    Wel=L012kb(φ)2dS+L012ks(vφ)2dS+L012ke(u)2dS++L012km2γ2dS+L014km4γ4dS+L0αbγφdSL0αsγ(vφ)dSL0αeγudS, (2.3)

    where the material parameters kb, ks, ke, km2, and km4 are stiffnesses, while αb, αs, and αe are coupling coefficients; all these parameters have to be determined by a micro-macro identification and validated with experimental tests. This elastic energy represents the energy stored in a material due to deformation, therefore, it must be inherently positive because it represents the ability of the material to do work when it returns to its original shape. To ensure that the postulated energy Wel is positive definite, then, we can assume that the coefficients satisfy the following inequalities:

    kb>0,ks>0,ke>0,kbkekskm2α2skbkeα2ekbksα2bkeks>0,km4>0. (2.4)

    The first three contributions of the energy (2.3) represent the classical constitutive behavior of the extensible Timoshenko model. They are representative of the bending, the shear, and the elongation energy that can be stored in the beam. The other contributions newly introduced in (2.3), are linked to the energy associated with the microcracks. In particular, the terms quadratic and quartic in γ are the amount of elastic energy that can be stored in the microcracks. The idea behind that is related to the specific morphology of the microcracks. From a geometric perspective, ideally, a microcrack can be visualized as a coin-shaped empty space. The microcrack consists of two faces or lips on opposite sides, which delimit the crack. Each lip of the microcrack exhibits asperities that may interact when the two lips on the opposite side of a crack come into contact (see Figure 1). When this occurs, these asperities can bend and, therefore, store a certain amount of elastic energy. We postulate a material nonlinearity with the quartic term on the ground that many experimental observations show a macroscopic nonlinear behavior in cement-based materials even at the small displacement and deformation regime [76]. The last three contributions of Eq (2.3) stand for the coupling energy exchanged between the macroscopic bending deformation and the microscopic asperity deformation within the microcracks, between the macroscopic shear distortion of the beam and the asperity deformation, as well as between the macroscopic elongation of the beam and the asperity deformation. Naturally, we can assume that a bending, a shear, or a change-of-length deformation of the beam could be responsible for the sliding of the microcrack lips. We have to remark, though, that the effect of such a sliding is noticeable only if the opposite faces of the microcracks are pushed against each other. This means that this effect becomes significant only in the case of compression. When bending and shear deformation are activated, only the part of the cross-section interested in compression is affected by such a phenomenon. On the contrary, the tensile part is free from this type of energy exchange. However, since the model is mono-dimensional, we cannot distinguish between the compressed and stretched parts of the cross-section, and thus, we have only to consider whether or not a compressed region exists. Consequently, whenever the beam bends, it produces a compressed region, and, hence, we can imagine that this phenomenon can be activated in this simple 1D context. The virtual work exerted by the inner forces is straightforwardly computed by the first variation of the elastic energy (2.3) as:

    δWel=L0kbφδφdS+L0ks(vφ)δ(vφ)dS+L0keuδudS++L0km2γδγdS+L0km4γ3δγdSL0αb(φδγ+γδφ)dS+L0αs[(vφ)δγ+γδ(vφ)]dSL0αe(uδγ+γδu)dS, (2.5)

    and, by performing an integration by parts, we can rearrange the contributions of the internal elastic energy as follows:

    δWel=L0[(kbφ)+ks(vφ)(αbγ)αsγ]δφdS+(kbφαbγ)δφ|L0+L0[(keu)(αeγ)]δudS+(keuαeγ)δu|L0++L0[km2γ+km4γ3αbφαs(vφ)αeu]δγdS+L0{[ks(vφ)](αsγ)}δvdS+[ks(vφ)αsγ]δv|L0. (2.6)

    In order to model the process of dissipation, we take into account the virtual work carried out by the friction force applied at the microcrack face level, as follows:

    ˜δD=L0ζb|φ|tanh(η˙γ)δγdS+L0ζcςC|u|tanh(η˙γ)δγdS. (2.7)

    The parameters ζb and ζc are related to the friction coefficient for the bending deformation and the compression, respectively. The appearance of the absolute value of the derivative of the angle of rotation |φ| in the first contribution of Eq (2.7) is due to the fact that when a cross-section undergoes a change in rotation, this can lead to a compression that closes the microcracks, at least in some parts of the cross-section. On the other hand, in the second integral, we consider the term |u|, which represents a uniform compression within the cross-section that allows the microcracks to be closed. We have to remark that if the term |u| is originated by a tensile case, the dissipated energy associated with the second contribution must be erased from the model because there is no interaction between the microcrack asperities. For this reason, we introduce the boolean variable ςC that assumes the value 1 for compression and 0 for traction. The concept of friction force could be accurately modeled with a Coulomb behavior. However, due to the non-Lipschitz continuity of the forcing term (a sign function), we lose the uniqueness of the solution. To overcome this challenge, a smoother version of the sign function, namely, the 'tanh'-term has been developed to mimic the Coulomb behavior while avoiding the issue mentioned above. This approach has proven to be effective in ensuring the accuracy of simulations and models in a variety of contexts. Moreover, it introduces a viscous behavior for small velocity ˙γ which could be beneficial in some context, without mentioning that with the slope η, we can control the feature tuning of the mechanical response on the basis of experimental observations. Here, for the sake of simplicity, we consider the same value of η for both contributions in Eq (2.7). For a comprehensive understanding of the formulation of the dissipative term, refer to [77,78,79].

    The virtual work of external forces and torques can be expressed as:

    δWext=L0bx(S)δudS+Fxδu|L0+L0by(S)δvdS+Fyδv|L0+L0μ(S)δφdS+Wδφ|L0, (2.8)

    where we admit distributed forces bx and by in the x-direction and y-direction as well as torques μ per unit length, point forces Fx and Fy in the x-direction and y-direction, as well as torques W applied at both ends, compatible with the energy (2.3).

    By substituting the expressions (2.6)–(2.8) in the principle (2.2), the bulk equations are deduced as below:

    {[keu]+(αeγ)=bx[ks(vφ)]+(αsγ)=by[(kbφ)+ks(vφ)(αbγ)αsγ]=μkm2γ+km4γ3αbφαs(vφ)αeu=ζb|φ|tanh(η˙γ)ζcςC|u|tanh(η˙γ), (2.9)

    alongside the essential boundary conditions related to the values of u, v, and φ and the natural boundary conditions associated with the axial force, the shear force, and the bending moment:

    N=keuαeγ,T=ks(vφ)αsγ,M=kbφαbγ, (2.10)

    respectively. We remark that from the deduction of the PVW, no boundary condition is provided for the variable γ since, in the energy, this quantity does not appear with the spatial derivative. Naturally, in the actual concrete sample, we do not have access to the microcracks, so we cannot give any boundary conditions on that level.

    To evaluate the mechanical properties of cement-based materials, three-point flexural tests and compression tests are performed through numerical simulations to assess the predictive properties of the proposed model. The main advantage of these tests is the ease of specimen preparation and testing as well as widely available testing equipment. In the bending tests, a sample (in the shape of a parallelepiped of side d × d × L, namely, 25 × 25 × 87.5 cm) is placed on two supports positioned at a distance of =75 cm from each other, and a force is applied at the center on the top. These setups create a scenario where the material is subjected to both tension and compression, allowing for the measurement of various mechanical properties. The compression tests are instead performed on a cylindrical sample with a diameter ϕ of 11.28 cm and a height L of 22 cm. In particular, hereby, we are interested in evaluating the dissipative behavior of the specimen.

    The numerical computations are carried out using the commercial software COMSOL Multiphysics®, which enabled the direct use of Eq (2.2) with the weak form partial differential equation (PDE) package. Since a generalized continuum model of the first gradient in the kinematical descriptors is employed, we opted for the standard Lagrangian quadratic polynomials as the shape functions for the finite element interpolation. It is worth noting that said shape functions are particularly suited for such a formulation involving, at most, only the first derivative of the kinematical descriptors. For further details regarding the numerical implementation of similar problems, we refer the interested reader to [80,81] for the isogeometric analysis and [82,83,84,85] for lumped models.

    Specifically, we assumed for the considered material a Young modulus, Yc = 31.45 GPa, and a Poisson ratio ν=0.15. Using the isotropic material symmetry the shear modulus is, thus, Gc=Yc/[2(1+ν)]. This information can be used to evaluate the classical stiffnesses for the bending kb=YcJ, being J the second moment of area of the beam cross-section and for the shear stiffness ks=5/6Gcd2 for the three-point bending test, while ks=Gcπ(ϕ/2)2 is the expression considered in the cylinder specimen. The stiffness due to the stretching/compression deformation ke=YcAc, where Ac is the area of the cross-section. The slope characterizing the dissipative behavior in Eq (2.7) is set to be η=225 s/m. To summarize, all values needed for the simulations are reported in Tables 1 and 2 for the bending and compression tests, respectively. The process of identifying all the necessary parameters that characterize the model can pose a significant challenge due to the complex mechanical responses that must be considered. However, it is pertinent to note that specific techniques commonly used for complex generalized materials, such as digital image correlation (DIC), energy methods, and neural networks, can also be applied in this context. These methods have proven to be effective tools in similar situations, as evidenced by their successful application in previous studies (see, for instance, references [86,87,88,89,90,91,92,93,94,95]). To analyze the dissipation, an external cyclic force with a sinusoidal trend is applied to the sample, as follows:

    f(t)={Fp2[1cos(πfqt)]t<ts=1/fqFp+F02[1cos(2πfqt)]tts, (3.1)

    where the amplitude of oscillation is F0, and Fp is a small force set to ensure the adhesion and the closure of the microcracks with a pre-compression originated by the specific test (in the compression test, it is uniform, while in the bending test, it is related only to half part of the cross-section, where actually the dissipation occurs); in the numerical simulations, we set its value to Fp=0.1F0. The time ts=0.1 s defines the interval of application of the initial ramp of amplitude Fp (see Figure 2). The value of F0 has been meticulously selected to mitigate any potential growth of microcracks. The force magnitude applied during the two tests was appropriately small to ensure reliable and accurate results. Specifically, F0=100 kN for the compression tests and F0=15 kN for the three point bending tests. The frequency fq of the sinusoidally varying contribution is set to 10 Hz.

    Table 1.  Values of the coefficients used as a reference in the three-point flexural tests for the prism specimen.
    kb ks ke km2 km4
    1.023×107 N m2 7.121×108 N 1.544×109 N 7.5×108 N/m2 1.0×108 N/m4
    αb αs αe ζb ζc
    2.764×107 N 2.5×106 N/m 1.25×108 N/m 3.68×108 N 2.212×108 N/m

     | Show Table
    DownLoad: CSV
    Table 2.  Values of the coefficients used as a reference in the compression tests for the cylindrical specimen.
    kb ks ke km2 km4
    2.499×105 N m2 1.366×108 N 3.143×108 N 7.5×108 N/m2 1.0×108 N/m4
    αb αs αe ζb ζc
    9.48×106 N 2.5×106 N/m 1.25×108 N/m 3.68×106 N 2.212×108 N/m

     | Show Table
    DownLoad: CSV
    Figure 2.  Normalized force applied to the samples for the cyclic tests.

    The mechanical responses obtained performing finite-element-method-based numerical simulations are collected and discussed in this section. To begin, we consider two tests, the three-point and the compression one, with assumed reference parameters (see Tables 1 and 2) that allow us to mimic with reasonable accuracy the known experimental behavior of a building beam made of plain concrete. In addition to these reference cases, here we explore the influence of some crucial parameters, especially concerning the dissipative behavior of the material.

    Figure 3 shows a cycle of loading and unloading for the two tests, namely, the three-point bending test and the compression test. Therefore, we can compare the two cases. The pictures display the external load versus the displacement of the loading point. The cycle area has been computed using a numerical approximated integral exploiting the trapezoidal rule. For the three-point bending test, we get a dissipated energy of 0.0074 J, and for the compression test, we evaluate a dissipated energy of 0.1699 J.

    Figure 3.  Dissipative cycles for the three-point flexural test (a), and the compression test (b).

    In order to provide a comprehensive understanding of the analyzed phenomenon, Figures 4 and 5 depict the time histories of the relative slip variable γ and the friction forces, ζb|φ|tanh(η˙γ) and ζcςC|u|tanh(η˙γ), at the points of maximum load, respectively. These observations were made in the center of the beam during the three-point bending test and at the point where the load was applied in the compression test. It is worth noting that the behavior of these variables related to the mechanics of the microcracks is nonlinear; thus, we might expect nonlinear behavior even at the microscopic level.

    Figure 4.  Time history of the relative sliding, γ for the three-point flexural test at the middle point (a), and for the compression test at the loading point (b).
    Figure 5.  Time history of the friction force, ζb|φ|tanh(η˙γ), for the three-point flexural test at the middle point (a), and ζcςC|u|tanh(η˙γ) for the compression test at the loading point (b).

    The relative sliding at the level of microcracks, γ are depicted in Figure 6 at the time instant of about 0.15 s corresponding to a maximum in the load amplitude. For the three-point flexural test, the new variable γ has significant values only in the portion of the beam where there is a flexural deformation, which, in turn, is directly related to compression in half of the cross-section, where the microcracks close and, due to some distortions in the shape of the beam, we can experience some sliding at that level of observation. For the compression test, instead, we observe that γ is constant since the compression is as such.

    Figure 6.  The relative sliding at the level of microcracks γ at one maximum value of the force at about 0.15 s, for the three-point flexural test (a) and for the compression test (b).

    In order to obtain a more comprehensive understanding of the model outcomes, a parametric study is conducted. Specifically, we vary the amplitude of the friction force, denoted by ζb and ζc, by employing a scale factor, q. This approach allows us to investigate the effects of altering the frictional force on the model performance and overall behavior. Through this study, we are able to draw meaningful conclusions that can inform future research and improve our understanding of the mechanisms underlying the model. Figure 7 shows the results of such a parametric study. In fact, for different multiplying factors q, specifically {0.25,0.5,2,4,8}, we compute the loading-unloading cycles for the two categories of tests and evaluate the area of the cycles, i.e., the lost energy of the system. We get the dissipated energy {0.0040,0.0061,0.0074,0.0068,0.0047,0.0028} J for the three-point bending tests and larger values {0.0778,0.1283,0.1699,0.1675,0.1177,0.0676} J for the compression tests. These results are summarized in a plot in Figure 7. The dotted lines are regressed curves made from each series of six simulations made for the considered tests. The simulations of both tests show the same trend, highlighting the presence of a maximum of dissipated energy. This behavior is typical of phenomena with two competitive aspects. In this case, we have that with low friction forces, the energy dissipated is little; in this range, if the friction coefficient is increased, more energy is dissipated. On the other hand, when the friction force is too large, the relative motion of the microcrack faces becomes increasingly smaller as the friction force increases, and, therefore, the dissipated energy inevitably decreases. Consequently, it is possible to determine a friction coefficient such as to have the maximum dissipated energy in this framework. From the perspective of engineering the cementitious material, this aspect is crucial since acting only on increasing the friction coefficient within the microcracks can even be counterproductive if the friction effect is exaggerated.

    Figure 7.  Influence of the parameters ζb and ζc on the dissipative cycles for the three-point flexural test (a), and the compression test (b), respectively.

    Turning our focus to the coupling parameters, we analyze the effect of the coefficient αb increasing its value by 20 and 40% with respect to the reference value. Figure 8 presents the dissipative cycles obtained via simulations conducted for the previously considered tests. The plots depicted in the figure show that increasing the coupling αb results in a more considerable dissipation. For the three-point flexural test, we evaluate a dissipated energy of 0.0114 and 0.0167 J, respectively, when the coupling increases by 20 and 40%. The same analysis has been conducted for the coupling coefficient αs. However, since this coefficient is less significant in the overall behavior, it is observed that with the same changes with respect to the reference case, the dissipation is almost the same. Therefore, the shear coupling has been increased by 100 and 200%, in the case of the three-point flexural test, resulting in a dissipation of energy of 0.0078 and 0.0097 J, respectively (see Figure 8). Overall, the general trend is the same but less effective.

    Figure 8.  Influence of the parameter αb on the dissipative cycles for the three-point flexural test with an amplifier factor of 1.2 (a) and 1.4 (c), and of αs with 2 amplification (b), and 4 amplification (d).

    Similarly, in the compression test, we obtain 0.2554 J and 0.36589 J of dissipated energy for a 20 and 40% increase in the the coupling αe, respectively (see Figure 9).

    Figure 9.  Influence of the parameter αe on the dissipative cycles for the compressive test with an amplifier factor of 1.2 (a) and 1.4 (b).

    Therefore, in designing a building material to be earthquake-proof, i.e., capable of dissipating as much energy as possible, it seems very promising to concentrate our attention on those additives that increase these coupling coefficients without jeopardizing the mechanical strength and pursuing the optimal friction coefficient that provides the maximum level of dissipation simultaneously.

    Finally, regarding the nonlinear stiffness km4, we carry out simulations to explore the influence of such a parameter. Figure 10 shows the dissipative cycles obtained by setting high values of km4. The dissipated energy obtained is 0.0043 J for the three-point flexural test with km4=1×1019 N/m4. Meanwhile, for the compression test, 0.1210 J of energy is dissipated in the loading-unloading cycle with km4=1×1017 N/m4. Thus, a greater stiffening of the asperities leads to a decrease in the energy dissipated.

    Figure 10.  Influence of the parameter km4 on the dissipative cycles for the three-point flexural test (a), and the compression test (b).

    In this paper, we propose a Timoshenko beam model augmented with a microcrack sliding descriptor that provides a promising framework for describing the mechanical behavior of cement-based materials. It is a very effective and efficient modeling tool that provides a beneficial computational advantage in evaluating both the strength of the material and also its dissipative behavior. Indeed, by introducing the variable γ to represent the relative sliding of microcracks within the material, the model captures additional dissipative mechanisms that contribute to energy loss during loading-unloading cycles.

    Finite element method-based numerical simulations conducted using COMSOL Multiphysics demonstrated the effectiveness of the model in replicating experimental tests. The simulations revealed the influence of various parameters on the mechanical response of the material, including the dissipated energy and the behavior of kinematic descriptors such as longitudinal and transverse displacement, cross-section orientation, and relative sliding at microcracks.

    A parametric study investigating the effects of altering the frictional force parameters provided insights into the relationship between frictional forces and energy dissipation. The study revealed a nonlinear relationship between these parameters and dissipated energy, with an optimal frictional force value maximizing energy dissipation.

    The model predictions align well with known experimental behavior observed in flexural and compression tests of cement-based materials. This validation underscores the model ability to capture the complex mechanical response of such materials under loading and unloading conditions.

    The insights gained from this study can inform the design and optimization of cement-based structures, particularly in applications where energy dissipation and mechanical resistance are critical factors, for example, in the case of earthquakes. By accurately modeling the dissipation mechanisms within the material, engineers can develop more resilient and durable structures.

    Further research could focus on refining the model by incorporating additional complexities, such as heterogeneities in material properties and multi-axial loading conditions. Additionally, experimental validation of the model predictions using a wider range of test configurations and material compositions would enhance its applicability and robustness.

    Overall, the study underscores the importance of considering microstructural phenomena, such as microcrack sliding, in developing accurate models for predicting the mechanical behavior of cement-based materials. By integrating such phenomena into computational models, researchers can advance our understanding of material behavior and contribute to the development of more resilient and sustainable infrastructure solutions.

    G.A., C.C., L.M.T. and E.B.: Conceptualization, Idealization, Methodology, Formal Analysis, Numerical Simulation, Writing. E.B.: Supervision, Revising.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    The authors declare that they have no conflict of interest.



    Conflicts of interest



    The authors declare no conflict of interest.

    Author contributions



    MA conceived the idea and drafted the manuscript. MA, AASY, SN, and BRJ searched for the literature, while MA and SN wrote the manuscript and drew the diagrams. MA, AASY, SN, and BRJ revised the manuscript critically and approved the final draft. AASY supervised the whole process.

    [1] Kimura T, Egawa S (2018) Epidemiology of prostate cancer in Asian countries. Int J Urol 25: 524-531. https://doi.org/10.1111/iju.13593
    [2] Pernar CH, Ebot EM, Wilson KM, et al. (2018) The epidemiology of prostate cancer. Cold Spring Harbor Perspect Med 8: a030361-a030380. https://doi.org/10.1101/cshperspect.a030361
    [3] Adeloye D, David RA, Aderemi AV, et al. (2016) An estimate of the incidence of prostate cancer in Africa: A systematic review and meta-analysis. PLoS One 11: e0153496. https://doi.org/10.1371/journal.pone.0153496
    [4] Kang DY, Li HJ (2015) The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis. Medicine 94: e410-e418. https://doi.org/10.1097/MD.0000000000000410
    [5] Ferlay J, Colombet M, Soerjomataram I, et al. (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144: 1941-1953. https://doi.org/10.1002/ijc.31937
    [6] (2018) World Health OrganisationCancer Fact Sheets.WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
    [7] Taitt HE (2018) Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health 12: 1807-1823. https://doi.org/10.1177/1557988318798279
    [8] Campi R, Brookman-May SD, Subiela Henriquez JD, et al. (2018) Impact of metabolic diseases, drugs, and dietary factors on prostate cancer risk, recurrence, and survival: A systematic review by the European Association of Urology Section of Oncological Urology. Eur Urol Focus 5: 1029-1057. https://doi.org/10.1016/j.euf.2018.04.001
    [9] Miah S, Catto J (2014) BPH and prostate cancer risk. Indian J Urol 30: 214-218. https://doi.org/10.4103/0970-1591.126909
    [10] Fernández-Martínez AB, Bajo AM, Arenas ML, et al. (2010) Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1. Cancer Lett 299: 11-21. https://doi.org/10.1016/j.canlet.2010.07.019
    [11] Boyle P, Koechlin A, Bota M, et al. (2016) Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis. BJU Int 118: 731-741. https://doi.org/10.1111/bju.13417
    [12] Tan ME, Li J, Xu HE, et al. (2015) Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin 36: 3-23. https://doi.org/10.1038/aps.2014.18
    [13] Lee YJ, Park JE, Jeon BR, et al. (2013) Is prostate-specific antigen effective for population screening of prostate cancer? A systematic review. Ann Lab Med 33: 233-241. https://doi.org/10.3343/alm.2013.33.4.233
    [14] Negoita S, Feuer EJ, Mariotto A, et al. (2018) Annual report to the nation on the status of cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer 124: 2801-2814. https://doi.org/10.1002/cncr.31549
    [15] Zhang K, Aruva MR, Shanthly N, et al. (2008) PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer. J Nucl Med 49: 112-121. https://doi.org/10.2967/jnumed.107.043703
    [16] Litwin MS, Tan HJ (2017) The diagnosis and treatment of prostate cancer: a review. JAMA 317: 2532-2542. https://doi.org/10.1001/jama.2017.7248
    [17] Renard-Penna R, Cancel-Tassin G, Comperat E, et al. (2015) Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer. World J Urol 33: 929-936. https://doi.org/10.1007/s00345-015-1570-z
    [18] Ahmed HU, Bosaily ESA, Brown LC, et al. (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389: 815-822. https://doi.org/10.1016/S0140-6736(16)32401-1
    [19] Boesen L (2017) Multiparametric MRI in detection and staging of prostate cancer. Dan Med J 64: B5327.
    [20] Sosnowski R, Zagrodzka M, Borkowski T (2016) The limitations of multiparametric magnetic resonance imaging also must be borne in mind. Cent Eur J Urol 69: 22-23. https://doi.org/10.5173/ceju.2016.e113
    [21] Saini S (2016) PSA and beyond: alternative prostate cancer biomarkers. Cell Oncol 39: 97-106. https://doi.org/10.1007/s13402-016-0268-6
    [22] Zhao L, Yu N, Guo T, et al. (2014) Tissue biomarkers for prognosis of prostate cancer: A systematic review and meta-analysis. Cancer Epidem Biomar 23: 1047-1054. https://doi.org/10.1158/1055-9965.EPI-13-0696
    [23] Jedinak A, Loughlin KR, Moses MA (2018) Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer. Oncotarget 9: 32534-32550. https://doi.org/10.18632/oncotarget.25946
    [24] Wu D, Ni J, Beretov J, et al. (2017) Urinary biomarkers in prostate cancer detection and monitoring progression. Crit Rev Oncol Hemat 118: 15-26. https://doi.org/10.1016/j.critrevonc.2017.08.002
    [25] Tosoian JJ, Ross AE, Sokoll LJ, et al. (2016) Urinary biomarkers for prostate cancer. Urol Clin N Am 43: 17-38. https://doi.org/10.1016/j.ucl.2015.08.003
    [26] Luo Y, Gou X, Huang P, et al. (2014) The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis. Asian J Androl 16: 487-492. https://doi.org/10.4103/1008-682X.125390
    [27] Dijkstra S, Mulders PF, Schalken JA (2014) Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Clin Biochem 47: 889-896. https://doi.org/10.1016/j.clinbiochem.2013.10.023
    [28] Larsen LK, Jakobsen JS, Abdul-Al A, et al. (2018) Noninvasive detection of high-grade prostate cancer by DNA methylation analysis of urine cells captured by microfiltration. J Uroly 200: 749-757. https://doi.org/10.1016/j.juro.2018.04.067
    [29] Ratz L, Laible M, Kacprzyk LA, et al. (2017) TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells. Oncotarget 8: 25115-25130. https://doi.org/10.18632/oncotarget.15931
    [30] Sequeiros T, Bastarós JM, Sánchez M, et al. (2015) Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. Prostate 75: 1102-1113. https://doi.org/10.1002/pros.22995
    [31] Mengual L, Lozano JJ, Ingelmo-Torres M, et al. (2016) Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers. BMC Cancer 16: 76. https://doi.org/10.1186/s12885-016-2127-2
    [32] Fryczkowski M, Bułdak R, Hejmo T, et al. (2018) Circulating levels of omentin, leptin, VEGF, and HGF and their clinical relevance with PSA marker in prostate cancer. Dis Markers 2018: 3852401. https://doi.org/10.1155/2018/3852401
    [33] Dheeraj A, Tailor D, Deep G, et al. (2018) Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) regulates mitochondrial dynamics, EMT, and angiogenesis in progression of prostate cancer. Cancer Res 78: 1095. https://doi.org/10.1158/1538-7445.AM2018-1095
    [34] Wisniewski T, Zyromska A, Makarewicz R, et al. (2019) Osteopontin and angiogenic factors as new biomarkers of prostate cancer. Urol J 16: 134-140.
    [35] Prager AJ, Peng CR, Lita E, et al. (2013) Urinary aHGF, IGFBP3, and OPN as diagnostic and prognostic biomarkers for prostate cancer. Biomarkers Med 7: 831-841. https://doi.org/10.2217/bmm.13.112
    [36] Rivnyak A, Kiss P, Tamas A, et al. (2018) Review on PACAP-induced transcriptomic and proteomic changes in neuronal development and repair. Int J Mol Sci 19: 1020. https://doi.org/10.3390/ijms19041020
    [37] Ashina M, Martelletti P (2018) Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?. J Headache Pain 19: 33. https://doi.org/10.1186/s10194-018-0860-4
    [38] Johnson GC, Parsons R, May V, et al. (2020) The role of pituitary adenylate cyclase-activating polypeptide (PACAP) signaling in the hippocampal dentate gyrus. Front Cell Neurosci 14: 111. https://doi.org/10.3389/fncel.2020.00111
    [39] Hirabayashi T, Nakamachi T, Shioda S (2018) Discovery of PACAP and its receptors in the brain. J Headache Pain 19: 28. https://doi.org/10.1186/s10194-018-0855-1
    [40] Leyton J, Coelho T, Coy D, et al. (1998) PACAP (6–38) inhibits the growth of prostate cancer cells. Cancer Lett 125: 131-139. https://doi.org/10.1016/S0304-3835(97)00525-9
    [41] Derand R, Montoni A, Bulteau-Pignoux L, et al. (2004) Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion. Brit J Pharmacol 141: 698-708. https://doi.org/10.1038/sj.bjp.0705597
    [42] Couvineau A, Ceraudo E, Tan YV, et al. (2012) The VPAC1 receptor: structure and function of a class B GPCR prototype. Front Endocrinol 3: 139. https://doi.org/10.3389/fendo.2012.00139
    [43] Couvineau A, Tan YV, Ceraudo E, et al. (2013) Strategies for studying the ligand-binding site of GPCRs: Photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs. Method Enzymol 520: 219-237. https://doi.org/10.1016/B978-0-12-391861-1.00010-1
    [44] Starr CG, Maderdrut JL, He J, et al. (2018) Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships. Peptides 104: 35-40. https://doi.org/10.1016/j.peptides.2018.04.006
    [45] Jayawardena D, Guzman G, Gill RK, et al. (2017) Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine. Am J Physiol-Gastr L 313: G16-G25. https://doi.org/10.1152/ajpgi.00081.2017
    [46] Dorsam GP, Benton K, Failing J, et al. (2011) Vasoactive intestinal peptide signaling axis in human leukemia. World J Biol Chem 2: 146-160. https://doi.org/10.4331/wjbc.v2.i6.146
    [47] Garcı́a-Fernández MO, Solano RM, Carmena MJ, et al. (2003) Expression of functional PACAP/VIP receptors in human prostate cancer and healthy tissue. Peptides 24: 893-902. https://doi.org/10.1016/S0196-9781(03)00162-1
    [48] Moretti C, Mammi C, Frajese GV, et al. (2006) PACAP and type I PACAP receptors in human prostate cancer tissue. Ann NY Acad Sci 1070: 440-449. https://doi.org/10.1196/annals.1317.059
    [49] Tamas A, Javorhazy A, Reglodi D, et al. (2016) Examination of PACAP-like immunoreactivity in urogenital tumor samples. J Mol Neurosci 59: 177-183. https://doi.org/10.1007/s12031-015-0652-0
    [50] Ibrahim H, Barrow P, Foster N (2011) Transcriptional modulation by VIP: a rational target against inflammatory disease. Clin Epigenet 2: 213-222. https://doi.org/10.1007/s13148-011-0036-4
    [51] Gomariz RP, Juarranz Y, Carrión M, et al. (2019) An overview of VPAC receptors in rheumatoid arthritis: biological role and clinical significance. Front Endocrinol 10: 729. https://doi.org/10.3389/fendo.2019.00729
    [52] Couvineau A, Laburthe M (2012) VPAC receptors: structure, molecular pharmacology, and interaction with accessory proteins. Brit J Pharmacol 166: 42-50. https://doi.org/10.1111/j.1476-5381.2011.01676.x
    [53] Tripathi S, Trabulsi EJ, Gomella L, et al. (2016) VPAC1 targeted (64)Cu-TP3805 positron emission tomography imaging of prostate cancer: preliminary evaluation in man. Urology 88: 111-118. https://doi.org/10.1016/j.urology.2015.10.012
    [54] Arms L, Vizzard MA (2011) Neuropeptides in lower urinary tract function. Handbook of Experimental Pharmacology : 395-423. https://doi.org/10.1007/978-3-642-16499-6_19
    [55] Inbal U, Alexandraki K, Grozinsky-Glasberg S (2018) Gastrointestinal hormones in cancer. Encyclopedia of Endocrine Diseases. Oxford: Academic Press 579-586. https://doi.org/10.1016/B978-0-12-801238-3.95875-6
    [56] Tang B, Yong X, Xie R, et al. (2014) Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review). Int J Oncol 44: 1023-1031. https://doi.org/10.3892/ijo.2014.2276
    [57] Reubi JC (2000) In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues: clinical implications. Ann NY Acad Sci 921: 1-25. https://doi.org/10.1111/j.1749-6632.2000.tb06946.x
    [58] Thakur ML (2016) Targeting VPAC1 genomic receptors for optical imaging of lung cancer. Eur J Nucl Med Mol Imaging 43: S662-S663.
    [59] Tang B, Wu J, Zhu MX, et al. (2019) VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer progression via a novel autocrine mechanism. Oncogene 38: 3946-3961. https://doi.org/10.1038/s41388-019-0709-6
    [60] Truong H, Gomella LG, Thakur ML, et al. (2018) VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen. World J Urol 36: 719-726. https://doi.org/10.1007/s00345-018-2263-1
    [61] Liu S, Zeng Y, Li Y, et al. (2014) VPAC1 overexpression is associated with poor differentiation in colon cancer. Tumour Biol 35: 6397-6404. https://doi.org/10.1007/s13277-014-1852-x
    [62] Tang B, Xie R, Xiao YF, et al. (2017) VIP promotes gastric cancer progression via the VPAC1/TRPV4/Ca2+ signaling pathway. J Dig Dis 152: S836. https://doi.org/10.1016/S0016-5085(17)32886-X
    [63] Tripathi S, Trabulsi E, Kumar P, et al. (2015) VPAC1 targeted detection of genitourinary cancer: A urinary assay. J Nuclear Med 56: 388.
    [64] Delgado M, Pozo D, Ganea D (2004) The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56: 249-290. https://doi.org/10.1124/pr.56.2.7
    [65] Ganea D, Hooper KM, Kong W (2015) The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiol 213: 442-452. https://doi.org/10.1111/apha.12427
    [66] Wu F, Song G, de Graaf C, et al. (2017) Structure and function of peptide-binding G protein-coupled receptors. J Mol Biol 429: 2726-2745. https://doi.org/10.1016/j.jmb.2017.06.022
    [67] Moody TW (2019) Peptide receptors as cancer drug targets. Ann NY Acad Sci 1455: 141-148. https://doi.org/10.1111/nyas.14100
    [68] Latek D, Langer I, Krzysko K, et al. (2019) A molecular dynamics study of vasoactive intestinal peptide receptor 1 and the basis of its therapeutic antagonism. Int J Mol Sci 20: 4348-4369. https://doi.org/10.3390/ijms20184348
    [69] Langer I (2012) Conformational switches in the VPAC1 receptor. Brit J Pharmacol 166: 79-84. https://doi.org/10.1111/j.1476-5381.2011.01616.x
    [70] Santos R, Ursu O, Gaulton A, et al. (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16: 19-34. https://doi.org/10.1038/nrd.2016.230
    [71] de Graaf C, Song G, Cao C, et al. (2017) Extending the structural view of class B GPCRs. Trends Biochem Sci 42: 946-960. https://doi.org/10.1016/j.tibs.2017.10.003
    [72] Solano RM, Langer I, Perret J, et al. (2001) Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction. J Biol Chem 276: 1084-1088. https://doi.org/10.1074/jbc.M007696200
    [73] Jazayeri A, Doré AS, Lamb D, et al. (2016) Extra-helical binding site of a glucagon receptor antagonist. Nature 533: 274. https://doi.org/10.1038/nature17414
    [74] Parthier C, Reedtz-Runge S, Rudolph R, et al. (2009) Passing the baton in class B GPCRs: peptide hormone activation via helix induction?. Trends Biochem Sci 34: 303-310. https://doi.org/10.1016/j.tibs.2009.02.004
    [75] Ceraudo E, Hierso R, Tan YV, et al. (2012) Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction. FASEB J 26: 2060-2071. https://doi.org/10.1096/fj.11-196444
    [76] Hutchings CJ, Koglin M, Olson WC, et al. (2017) Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat Rev Drug Discov 16: 787-810. https://doi.org/10.1038/nrd.2017.91
    [77] Peyrassol X, Laeremans T, Lahura V, et al. (2018) Development by genetic immunization of monovalent antibodies against human vasoactive intestinal peptide receptor 1 (VPAC1), new innovative, and versatile tools to study VPAC1 receptor function. Front Endocrinol 9: 153. https://doi.org/10.3389/fendo.2018.00153
    [78] Freson K, Peeters K, De Vos R, et al. (2008) PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications. Blood 111: 1885-1893. https://doi.org/10.1182/blood-2007-06-098558
    [79] Hermann RJ, Van der Steen T, Vomhof-Dekrey EE, et al. (2012) Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry. J Immunol Methods 376: 20-31. https://doi.org/10.1016/j.jim.2011.10.009
    [80] Langlet C, Langer I, Vertongen P, et al. (2005) Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling. J Biol Chem 280: 28034-28043. https://doi.org/10.1074/jbc.M500449200
    [81] Ramos-Álvarez I, Mantey SA, Nakamura T, et al. (2015) A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists. Peptides 66: 26-42. https://doi.org/10.1016/j.peptides.2015.01.009
    [82] Van Rampelbergh J, Juarranz MG, Perret J, et al. (2000) Characterization of a novel VPAC1 selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition. Brit J Pharmacol 130: 819-826. https://doi.org/10.1038/sj.bjp.0703384
    [83] Dickson L, Aramori I, McCulloch J, et al. (2006) A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology. Neuropharmacol 51: 1086-1098. https://doi.org/10.1016/j.neuropharm.2006.07.017
    [84] Moody TW, Nuche-Berenguer B, Jensen RT (2016) Vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide, and their receptors and cancer. Curr Opin Endocrinol 23: 38-47. https://doi.org/10.1097/MED.0000000000000218
    [85] Moody TW, Chan D, Fahrenkrug J, et al. (2003) Neuropeptides as autocrine growth factors in cancer cells. Curr Pharm Design 9: 495-509. https://doi.org/10.2174/1381612033391621
    [86] Fernández-Martínez AB, Carmena MJ, Bajo AM, et al. (2015) VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells. Cell Signal 27: 236-244. https://doi.org/10.1016/j.cellsig.2014.11.005
    [87] Iwasaki M, Akiba Y, Kaunitz JD (2019) Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Research 8: 1629-1642. https://doi.org/10.12688/f1000research.18039.1
    [88] Langer I (2012) Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies. Front Endocrin 3: 129. https://doi.org/10.3389/fendo.2012.00129
    [89] Harmar AJ, Fahrenkrug J, Gozes I, et al. (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase—activating polypeptide: IUPHAR Review 1. Brit J Pharmacol 166: 4-17. https://doi.org/10.1111/j.1476-5381.2012.01871.x
    [90] Langer I, Robberecht P (2007) Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors. Biochem Soc Trans 35: 724-728. https://doi.org/10.1042/BST0350724
    [91] Igarashi H, Fujimori N, Ito T, et al. (2011) Vasoactive intestinal peptide (VIP) and VIP receptors-elucidation of structure and function for therapeutic applications. Int J Clin Med 2: 500-508. https://doi.org/10.4236/ijcm.2011.24084
    [92] Delgado M, Ganea D (2000) Inhibition of IFN-gamma-induced Janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J Immunol 165: 3051-3057. https://doi.org/10.4049/jimmunol.165.6.3051
    [93] Smalley SGR, Barrow PA, Foster N (2009) Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease. Clin Exp Immunol 157: 225-234. https://doi.org/10.1111/j.1365-2249.2009.03956.x
    [94] Shaywitz AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68: 821-861. https://doi.org/10.1146/annurev.biochem.68.1.821
    [95] Delgado M, Ganea D (2001) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J Biol Chem 276: 369-380. https://doi.org/10.1074/jbc.M006923200
    [96] Dickson L, Finlayson K (2009) VPAC and PAC receptors: From ligands to function. Pharmacol Therapeut 121: 294-316. https://doi.org/10.1016/j.pharmthera.2008.11.006
    [97] Laburthe M, Couvineau A, Tan V (2007) Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology. Peptides 28: 1631-1639. https://doi.org/10.1016/j.peptides.2007.04.026
    [98] Collado B, Sánchez MG, Díaz-Laviada I, et al. (2005) Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation. Biochim Biophys Acta Mol Cell Res 1744: 224-233. https://doi.org/10.1016/j.bbamcr.2005.04.009
    [99] Park MH, Hong JT (2016) Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches. Cells 5: 15. https://doi.org/10.3390/cells5020015
    [100] Grosset AA, Ouellet V, Caron C, et al. (2019) Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network. PLoS Med 16: e1002847. https://doi.org/10.1371/journal.pmed.1002847
    [101] Staal J, Beyaert R (2018) Inflammation and NF-κB signaling in prostate cancer: mechanisms and clinical implications. Cells 7: 122. https://doi.org/10.3390/cells7090122
    [102] Thomas-Jardin SE, Dahl H, Nawas AF, et al. (2020) NF-κB signaling promotes castration-resistant prostate cancer initiation and progression. Pharmacol Therapeut 211: 107538. https://doi.org/10.1016/j.pharmthera.2020.107538
    [103] Jain G, Cronauer MV, Schrader M, et al. (2012) NF-kappaB signaling in prostate cancer: a promising therapeutic target?. World J Urol 30: 303-310. https://doi.org/10.1007/s00345-011-0792-y
    [104] Moreno P, Ramos-Álvarez I, Moody TW, et al. (2016) Bombesin-related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting, and treatment. Expert Opin Ther Targets 20: 1055-1073. https://doi.org/10.1517/14728222.2016.1164694
    [105] Ramos-Álvarez I, Moreno P, Mantey SA, et al. (2015) Insights into bombesin receptors and ligands: Highlighting recent advances. Peptides 72: 128-144. https://doi.org/10.1016/j.peptides.2015.04.026
    [106] Baratto L, Jadvar H, Iagaru A (2018) Prostate cancer theranostics targeting gastrin-releasing peptide receptors. Mol Imaging Biol 20: 501-509. https://doi.org/10.1007/s11307-017-1151-1
    [107] Moody TW, Ramos-Alvarez I, Jensen RT (2018) Neuropeptide G protein-coupled receptors as oncotargets. Front Endocrinol 9: 345-345. https://doi.org/10.3389/fendo.2018.00345
    [108] Dai J, Shen R, Sumitomo M, et al. (2002) Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Clin Cancer Res 8: 2399.
    [109] Putney JW, Tomita T (2012) Phospholipase C signaling and calcium influx. Adv Biol Regul 52: 152-164. https://doi.org/10.1016/j.advenzreg.2011.09.005
    [110] Weber HC (2009) Regulation and signaling of human bombesin receptors and their biological effects. Curr Opin Endocrinol 16: 66-71. https://doi.org/10.1097/MED.0b013e32831cf5aa
    [111] Fujita K, Pavlovich CP, Netto GJ, et al. (2009) Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. Hum Pathol 40: 924-933. https://doi.org/10.1016/j.humpath.2009.01.004
    [112] Fujita K, Nonomura N (2018) Urinary biomarkers of prostate cancer. Int J Urol 25: 770-779. https://doi.org/10.1111/iju.13734
    [113] Wei JT (2015) Urinary biomarkers for prostate cancer. Curr Opin Urol 25: 77-82. https://doi.org/10.1097/MOU.0000000000000133
    [114] Trabulsi EJ, Tripathi SK, Gomella L, et al. (2017) Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study. BJU Int 119: 885-895. https://doi.org/10.1111/bju.13775
    [115] Trabulsi E, Tripathi S, Calvaresi A, et al. (2016) VPAC1 in shed urinary cells—A potential genitourinary cancer biomarker. J Urol 195: e12. https://doi.org/10.1016/j.juro.2016.02.1880
    [116] Hoepel J (2021) Unraveling the mechanisms of antibody-dependent inflammation [PhD's thesis]. University of Amsterdam, Netherlands .
    [117] Lagerström MC, Schiöth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7: 339-357. https://doi.org/10.1038/nrd2518
    [118] Pediani JD, Ward RJ, Marsango S, et al. (2018) Spatial intensity distribution analysis: studies of G protein-coupled receptor oligomerisation. Trends Pharmacol Sci 39: 175-186. https://doi.org/10.1016/j.tips.2017.09.001
    [119] Hutchings CJ, Koglin M, Marshall FH (2010) Therapeutic antibodies directed at G protein-coupled receptors. mAbs 2: 594-606. https://doi.org/10.4161/mabs.2.6.13420
  • This article has been cited by:

    1. Larry Murcia Terranova, Christian Cardillo, Giuliano Aretusi, An enhanced beam model incorporating a hysteresis-based solid friction damping mechanism for cementitious materials, 2025, 37, 0935-1175, 10.1007/s00161-024-01335-y
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3079) PDF downloads(212) Cited by(1)

Figures and Tables

Figures(3)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog